Opthea Limited, a biotechnology company, develops and markets therapies primarily for eye diseases in Australia. The company is headquartered in South Yarra, Australia.
Click "Analyze" to generate stock analysis
OPT Price Trend and Signals
OPT Financials
2025-03-13Somewhat Bearishprice_signal
Yearly low detected.
2025-03-11Somewhat Bearishprice_signal
Yearly low detected.
2025-03-10Somewhat Bearishprice_signal
Monthly low detected.
2025-03-07Somewhat Bearishprice_signal
Monthly low detected.
2025-03-06Somewhat Bearishprice_signal
Monthly low detected.
2025-03-04Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-03-04Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-03-04Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-03-04Somewhat Bearishprice_signal
Monthly low detected.
2025-03-04Bearishprice_signal
Large price change detected: -30.53%.
2025-03-03Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-03-03Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-03-03Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-03-03Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.